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Objective. Countries and regions vary substantially in transport related physical activity that people gain from
walking and cycling and in how this varies by age and gender. This study aims to quantify the population health
impacts of differences between four settings.
Method. The Integrated Transport and Health Model (ITHIM) was used to estimate health impacts from
changes to physical activity thatwould arise if adults in urbanareas in England andWales adopted travel patterns
of Switzerland, theNetherlands, and California. Themodelwas parameterisedwith data from travel surveys from
each setting and estimated usingMonte Carlo simulation. Two types of scenarios were created, one inwhich the
total travel time budget was assumed to be ﬁxed and one where total travel times varied.
Results. Substantial population health beneﬁts would accrue if people in England andWales gained as much
transport related physical activity as people in Switzerland or the Netherlands, whilst smaller but still consider-
able harms would occur if active travel fell to the level seen in California. The beneﬁts from achieving the travel
patterns of the high cycling Netherlands or high walking Switzerland were similar.
Conclusion.Differences between high income countries in how people travel have important implications for
population health.
© 2015 Published by Elsevier Inc.
Introduction
Regular physical activity provides a wide range of health beneﬁts.
Active travel (primarily walking and cycling) has gained attention
from the transport and environmental sectors for its advantages as
low-emission and space-efﬁcient travel modes (Banister, 2008). Active
travel is also increasingly recognized for its potential to contribute to
overall physical activity (Craig et al., 2012; Dora, 1999). As active travel
combines mobility and activity, it may offer a lower hurdle to be active
than sports or other recreational activity. Nonetheless, steps to increase
active travel have generally beenhesitant, although some countries (e.g.
the Netherlands, Switzerland, Germany or Denmark) have been more
proactive than others (e.g. UK, USA). Health impact modelling is used
to quantify effects of active travel on health outcomes in a speciﬁed
population and as such can support informed decision making and
cost-effective investment of limited resources.
In recent years, various methods to model health impacts of active
travel have been developed. These typically compare beneﬁts of physi-
cal activity with potential harms from injury risk and increased
exposure to air pollution. When modelling substantial changes at the
population level, such studies have overwhelmingly found large net
beneﬁts from active travel (de Hartog et al., 2010; Rabl and De
Nazelle, 2012; Rojas-Rueda et al., 2011, 2013; Woodcock et al., 2013,
2014), although this may not apply in younger age groups when injury
risks are high (Woodcock et al., 2014).
Typically health impact models of transport have used hypothetical
scenarios with simplistic assumptions on changes in active travel (e.g.
de Hartog et al., 2010; Gotschi, 2011; Grabow et al., 2011; Kahlmeier
et al., 2011). Such studies may arguably struggle to realistically reﬂect
travel behaviour, particularly in the context of advanced models
which consider distributions of physical activity across age and gender.
The objective of this study is therefore to create alternative scenarios
using data from major travel surveys reﬂecting population-wide distri-
butions of travel behaviour, in particular across age and gender. England
and Wales (E&W) served as the reference scenario. To illustrate the
potential range of the magnitude of health impacts from changes in
active transport, comparison areas were chosen for exceptionally high
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or low levels of active transport, respectively. Speciﬁcally, the health
impacts on the urban population of E&W were modelled, assuming
shifts to travel patterns of Switzerland, the Netherlands, and California.
Methods
Travel survey data
Travel survey data were used from E&Wand three comparison areas select-
ed based on substantial contrasts in travel patterns, namely Switzerland for high
levels of walking, the Netherlands for high levels of bicycling, and California for
high levels of car usage. As such, they were used to inform hypothetical yet
realistic scenarios for the population of E&W. Table 1 shows descriptive data
of E&W and the three comparison areas.
Data on travel patterns were extracted from national travel surveys
(Bundesamt für Statistik et al., 2007; Department of Transport, 2013; Federal
Highway Administration, 2010; Ministerie van Verkeer en Waterstaat, 2010)
(Supplementary Table A.1). To increase survey comparability, small communi-
ties of less than 10,000 inhabitants were excluded, and minimum trip duration
was standardized to 3 min.
Health impact modelling
Health impacts were modelled as changes in population health due to
changes in active travel time (walking, cycling) in the E&W population. The
model was estimated using Monte Carlo simulation in Analytica version 4.4.
(www.lumina.com), running 50,000 iterations. The current E&W travel pattern
was compared against the counterfactual scenarios in which E&Wwould adopt
the travel patterns fromSwitzerland, theNetherlands or California, respectively.
Travel patterns were modelled as changes in absolute terms (minutes of each
mode), as well as relative terms (percent of total travel time of each mode).
Travel behaviour was modelled as population wide distributions of travel
times spent in different modes, stratiﬁed by sex and age groups for E&W and
each comparison area. For all other variables, i.e. age distribution, background
mortality and morbidity rates, age and sex-speciﬁc E&W data was used.
The study was conducted using a substantially improved and updated
version of the Integrated Transport and Health Impact Modelling tool (ITHIM)
(Woodcock, 2014), which now models variability and uncertainty of parame-
ters using Monte Carlo simulation. Earlier versions were previously described
elsewhere (Maizlish et al., 2013; Woodcock et al., 2013, 2014). ITHIM was
used to model health beneﬁts of physical activity using a range of non-linear
dose–response functions speciﬁc to exposure domains (total physical activity,
non-work physical activity, or physical activity from active travel) and out-
comes (all cause mortality, morbidities). Because most previous health impact
models of active travel found that associated risks are at least one order of
magnitude smaller than beneﬁts of physical activity when changes are
modelled across all age groups (de Hartog et al., 2010; Rabl and De Nazelle,
2012; Rojas-Rueda et al., 2011), the approach to impact modelling presented
here is only applied to impacts from physical activity.
Aggregation of background physical activities reﬂected intensity of speciﬁc
activities, estimated in Metabolic Equivalents of Task (METs), as listed in the
Compendium of Physical Activity (Ainsworth et al., 2011). Activities under
1.5 METs were excluded. METs were converted into marginal METs by
subtracting 1 MET (intensity of being at rest). This approach only considers
the activity over and above the metabolic activity at rest. Variation in METs for
each activity was taken into account stochastically to generate distributions of
METs within age and gender strata (Table 2).
Age (15+) and gender speciﬁc data on walking, cycling, household work,
sport and work included estimates of variability and were available from
the health survey for England (Craig and Mindell, 2013). Background physical
activity was assumed to remain unchanged throughout the different scenarios
(Supplementary Table A.2).
Health beneﬁts of physical activity were modelled using disease speciﬁc
incidence and mortality of stroke, ischemic heart disease (IHD), other car-
diovascular and circulatory diseases, type-2 diabetes, colon cancer, breast
cancer, dementia and Alzheimer's disease, and depression. The doses were
recalculated from Woodcock et al. (2009) as marginal MET/h week. See
Table 3 for dose–response parameters. As part of sensitivity analysis, two al-
ternative approaches to model impacts on all-cause mortality were applied,
using relative risks from a systematic review byWoodcock et al. (2011) and
a dose–response function presented in a recent large cohort study (Wen
et al., 2011), respectively (Supplementary Table A.3).
A log-linear relationship was assumed between exposures and the health
outcomes. Beyond this the exposure variables were transformed (using power
transformations 0.25 to 1) (Sattelmair et al., 2011; Woodcock et al., 2011).
Since the exact parameters of the non-linear dose–response function are
unknown, these were stochastically allowed to vary across iterations of the
model (see Supplementary Fig. B.1) and evaluated in sensitivity analyses.
Burden of disease data for the UK, including mortality rates as well as
disability adjusted life years (DALYs), years of healthy life lost due to disability
(YLDs) and years of life lost (YLLs), were obtained from the Global Burden of
Disease (GBD) study 2010 (IHME, 2013) and adjusted to reﬂect E&W popula-
tion size, and age and gender distribution. Supplementary Table A.4 presents
size and age distribution and Supplementary Table A.5 the burden of disease
for the study population.
Sensitivity of themodel to selected parameters was illustratedwith tornado
plots (Table 2, Supplementary Table A.6 and Fig. B.2).
Results
Travel behaviour patterns
The three international comparison areas reveal substantial contrasts
compared with E&W, both in terms of absolute travel times as well as
relative distribution across travel modes assuming a constant travel
time budget (Table 4). Overall, the data showed travel time to be highest
in Switzerland at over 80min per day, comparedwith fewer than 60min
in E&W. Californians drive the most, almost 1 h per day, compared with
only around 35 min in E&W. The small differences for driving times be-
tween the different European settings reﬂect the fact that the Swiss
Table 1
Descriptive data on E&W and three comparison areas.
England & Wales (study area) Switzerland Netherlands California
Population (million) 55.6 (2010)a 8.0 (2011) 16.8 (2014) 38.3 (2013)
Area 151,036 km2 41,285 km2 41,543 km2 423,970 km2
Population density b 370/km2 188/km2 405/km2 95/km2
Gross domestic product (GDP)/capita ($) 37 k (UK) 54 k 42 k 46 k (USA)
Cars per household 1.2 (2011)b 1.15 (2010)c 1.0 (2005)d 2.2 (2010)e
Share of trips by walking and cycling 26% (UK, 2008)f 50% (2010)d 51% (2008)g 23% (2012)h
Sources: (Wikipedia, 2014), if not otherwise stated. See footnotes.
a http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates-for-uk–england-and-wales–scotland-and-northern-ireland/mid-2001-to-mid-2010-revised/index.html
b http://www.ons.gov.uk/ons/rel/census/2011-census/key-statistics-for-local-authorities-in-england-and-wales/index.html
c Bundesamt für Statistik and Bundesamt für Raumentwicklung, 2012. Mobilität in der Schweiz: Ergebnisse des Mikrozensus Mobilität und Verkehr 2010. BfS, ARE, Neuchâtel.
d http://www.cbs.nl/en-GB/menu/themas/dossiers/nederland-regionaal/publicaties/artikelen/archief/2007/2007-2127-wm.htm
e http://www.clrsearch.com/Sacramento-Demographics/CA/Number-of-Vehicles-per-Household
f https://www.gov.uk/government/collections/national-travel-survey-statistics
g Ministerie van Verkeer en Waterstaat, 2010. “Onderzoek Verplaatsingen in Nederland” (OViN).
h Federal Highway Administration, 2010. National Household Travel Survey. US Department of Transportation.
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andDutchmake fewer short butmore longer trips by car, comparedwith
E&W (data not shown).
The Dutch ranks the highest for cycling, at 12min per day compared
to only about 1 min per day in E&W. Levels of walking are highest in
Switzerland at around 25 min per day.
Gender and age distributions of active travel are of interest both in
planning— as indicators as to howwell the environment supports active
travel across the life course, and in health impact modelling (Table 4,
Fig. 1 and Supplementary Fig. B.3). Walking is on balance slightly
more common amongst women, whilst cycling shows a clear gender
gap in favour of men in E&W and California, with almost three times
lower values forwomen. In theNetherlands, where cycling ismost pop-
ular and safest (Pucher and Buehler, 2008), there is no gender gap.
In E&Wand California,walking levels are the highest amongst youn-
ger generations and decline with increasing age. In Switzerland and the
Netherlands, walking levels increase with age and only drop notably in
old age (80+). For cycling, the decline with increasing age is dramatic
in E&W, California and, albeit somewhat delayed, in Switzerland. In
the Netherlands, cycling levels only decline after age 70 (Fig. 1).
Health impacts
Estimated health impacts for adopting absolute travel times are
presented in Table 5a, whilst Table 5b shows results for adopting
proportions of travel time spent in different modes but keeping total
travel time as at present. Every year, approximately 2.8 million DALYs
are lost in E&Wdue to diseases associatedwith inactivity, i.e. cardiovas-
cular diseases, breast and colon cancer, type-2 diabetes, dementia, and
depression. This includes 167,000 deaths. Adopting time spent walking
and cycling from Switzerland or the Netherlands, with substantially
higher proportions of active travel, would prevent between 10,000
and 17,000 premature deaths, or between 150,000 to 250,000 DALYs,
per year. On the other hand, adopting the travel pattern of California
with less active travel would lead to additional 1700–3100 deaths, or
34,000–56,000 DALYs in E&W. Approximately half of the impacts on
DALYs and deaths are attributable to IHD in males, and to IHD and
stroke combined, in females. This reﬂects both the high incidence
rates of IHD and stroke and their strong relationship with physical
activity (Table 3).
Supplementary Table A.3 shows the sensitivity of impact estimates
for deathswhen applying different dose–response functions. In general,
the health beneﬁts and risks are two times larger when using the dose–
response function for all-cause mortality presented by Woodcock et al.
2011 and three times larger when using the one from Wen et al.
(2011), compared with the sum of deaths from the disease speciﬁc
mortality model (Table 5a).
Tornado plot analyses showed that the model was most sensitive
to assumptions on intensity of walking (METs), the shape of the dose–
response function and the RR for stroke, IHD and other cardiovascular
and circulatory diseases (Supplementary Fig. B.2). The relative contribu-
tion of these parameters to model uncertainty varied depending on the
comparison being made.
Discussion
Findings from this study imply that large, population level shifts in
travel behaviour of E&Wwould translate into health impacts of signiﬁ-
cant magnitude. All else equal, adoption of high rates of active travel
comparable to Switzerland or the Netherlands would result in the
prevention of approximately 6–10% of all deaths caused by diseases
associated with physical inactivity, and about 3–4% of all deaths due to
all causes. Conversely, a shift towards somewhat lower levels ofwalking
similar to California would result in up to 3000 additional premature
deaths annually.
The comparisons also show that higher levels of active travel do not
automatically correspondwith less driving, which suggests that achiev-
ing high levels of active travel is not likely to be sufﬁcient in itself to
reduce carbon emissions unless there is also a policy to tackle longer
Table 2
Intensity parameters used to derive background physical activity and physical activity from active travel. (Source: Compendium of Physical Activities (https://sites.google.com/site/
compendiumofphysicalactivities/) (Ainsworth et al., 2011)).
Physical
activity
Estimate
(marginal
METs)
Distribution Description in compendium of physical activities (Ainsworth et al., 2011)
Walking Mean: 2.5 Lognormal
(stddev:1.6)
Mean MET (3.5) refers to METs for “walking for pleasure.” Variability by author judgement.
Cycling Median: 5.8 LogNormal
(gsdev:1.3)
Median MET (6.8) refers to METs for “bicycling, to/from work, self selected pace.” Variability by author judgement.
Household
work
Median: 3.5 LogNormal
(gsdev:1.5)
Median MET (4.5) refers to METs for “polishing ﬂoors, standing, walking slowly, using electric polishing machine.”
Variability by author judgement.
Sports Median:5 LogNormal
(gsdev:1.5)
Median MET (6.0) refers to METs for “volleyball, competitive, in gymnasium.” Variability by author judgement.
aMET is deﬁned as the ratio of activity speciﬁc metabolic rate to a standard resting metabolic rate of 1.0 (1.0 kcal/(kg ∗ h) or 4.184 kJ/(kg ∗ h)) ((Ainsworth et al., 2000)). Marginal METs
refer to the intensity of activity over and above the resting metabolic rate. Marginal METh/wk are calculated as (MET rate - 1) * hours of activity.
Table 3
Dose–response parameters for different diseases.
Disease RR (mean (std))a Corresponding exposure marginal MET
h/week)b
Reference
Stroke; ischemic heart disease (IHD); other cardiovascular
and circulatory diseases
0.84 (0.03) 5.4 Hamer and Chida (2008)
Type-2 diabetes 0.83 (0.04) 5.6 Jeon et al. (2007)
Colon cancer Men: 0.80 (0.08);
women: 0.86 (0.06)
Men 24.1; women 23.3 Harriss et al. (2009)
Breast cancer 0.94 (0.01) 3.5 Monninkhof et al. (2007)
Dementia and Alzheimer's disease 0.72 (0.07) 24.5 Hamer and Chida (2009)
Depression 0.96 (0.02) 0.8 Paffenbarger et al. (1994)
a Means and standard deviations are based on a normal distribution.
b E.g. RR of 0.84 moving from no activity to 5.4 marginal MET h/week.
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car trips. Both the Swiss and Dutch spent similar time driving as people
in E&W, but less so for short trips. Instead, there is a greater share of
inter-urban car trips between more closely linked urban systems in
these densely populated countries (Limtanakool et al., 2006).
Study limitations and strengths
ITHIM is characterized by a number of strengths, compared with
other similar models. In particular, it considers morbidity and not just
deaths, population wide distributions of travel times, and health
relevant parameters, such as gender, age, background disease rates
and physical activity. It applies more realistic non-linear dose–response
functions and estimates a set of different health measures.
The presented analysis uses empirical travel survey data to inform
scenarios of shifts in travel patterns, which provide realistic population
wide distributions of active travel by age and gender. For example, older
age groups have higher health risks and therefore beneﬁt more from
relative risk reductions due to active travel. Typically, HIA rely on
average effects. For example, the WHO HEAT tool (www.euro.who.int/
HEAT) provides an approach that is conservative in excluding effects
amongst older adults but may be optimistic in not differentiating be-
tween younger and middle-aged adults. In contrast, the presented ap-
proach considers realistic age and gender distributions in its scenarios.
For example, increasing cycling to levels of the Netherlandsmeans sub-
stantial increases in cycling in elderly and women (see Figs. 1 and B.3).
The two ways how travel patterns were applied are indicative of
the range of resulting beneﬁts. Achieving absolute travel times reﬂects
more accurately our best estimates of how people in the different coun-
tries currently behave. However, increasing total travel times may be
seen as undesirable and achieving changing the relative time spent
might be a more appropriate policy target. It should also be noted that
differences in total travel time between the settings may in part reﬂect
differences in survey methods. Despite attempts to standardize, the
comparison data entail inherentmethodological differences (e.g. survey
questions and periods) as well as local differences (e.g. land use and
urban/rural mix).
To what extent and how such travel patterns could be adopted
remains uncertain. Climate does not provide a good explanation of the
differences in travel (Pucher and Buehler, 2006). Although the
Netherlands has a favourable topography for cycling there are many
ﬂat areas in E&W without much cycling. The advent of electric assist
bikes also offers the potential to reduce the burden of cycling in hillier
areas. Probably of greater importance are high quality and safe
infrastructure (Pucher and Dijkstra, 2003), as is in place in the
Netherlands for cycling, synergies with public transport, as in
Switzerland where public transport is fed by a huge number of walking
trips (also see Table 4), and a generally supportive culture towards
active travel (Heinen et al., 2010). Robust evidence on the beneﬁcial
effects on total physical activity of provision of trafﬁc free walking and
cycling routes is emerging from the UK (Goodman et al., 2014), and
studies have shown a positive increase in cycling following city level
programmes in England (Goodman et al., 2013). However, overall
quantitative effects of speciﬁc policies remain poorly understood
(Goodman et al., 2014; Pucher et al., 2010), and depend on cultural
context that may require adapted local approaches (Aldred and
Jungnickel, 2014). Well documented is the correlation between levels
of active transport and trafﬁc safety (Elvik, 2009; Jacobsen, 2003;
Pucher andDijkstra, 2003). Perceived risks are amajor barrier to cycling
and to an extent to walking, and increasing objective and subjective
safety in amanner that does not detract frommode convenience should
be considered by all policies to promote active travel.
Interestingly the beneﬁts in E&W from adopting travel patterns
from the Netherlands or Switzerland were similar. Based on absolute
travel times, beneﬁts from Swiss travel (mainly walking) were greater
in part because the Swiss spend more time travelling than people in
the other settings. If insteadwe assume that the English andWelsh trav-
el time budget remains constant but is proportioned out differently,
then the beneﬁts from Dutch travel were greater.
Several methodological considerations are of importance when
interpreting the presented health impacts. Because the dose–response
Table 4
Daily averagea travel times (minutes (% of total travel time)) by mode in E&W and three
comparison areas.
England &
Wales
Switzerland Netherlands California
Male
Walk 10.7 (17.6%) 23.4 (25.4%) 9.3 (12.2%) 7.5 (9.4%)
Cycle 1.4 (2.3%) 4.5 (4.9%) 12.7 (16.6%) 2.0 (2.5%)
Public transport 7.1 (11.7%) 13.9 (15.1%) 8.7 (11.3%) 5.9 (7.4%)
Car 38.1 (62.5%) 44.7 (48.5%) 40.7 (53.2%) 61.8 (77.5%)
Other 3.6 (6.0%) 5.6 (6.1%) 5.1 (6.7%) 2.5 (3.1%)
Total 61.0 (100.0%) 92.1 (100.0%) 76.4 (100.0%) 79.8 (100.0%)
Female
Walk 12.4 (22.3%) 28.5 (36.1%) 10.4 (16.6%) 8.9 (12.1%)
Cycle 0.4 (0.7%) 2.9 (3.7%) 11.7 (18.7%) 0.5 (0.7%)
Public transport 7.8 (14.1%) 14.0 (17.7%) 8.7 (13.9%) 6.3 (8.5%)
Car 34.1 (61.5%) 31.1 (39.4%) 28.6 (45.4%) 56.8 (77.2%)
Other 0.8 (1.4%) 2.4 (3.1%) 3.4 (5.5%) 1.1 (1.5%)
Total 55.4 (100.0%) 78.9 (100.0%) 62.9 (100.0%) 73.6 (100.0%)
a The data is population based including people who did not travel. Communities
b10,000 and subjects b16 years are excluded.
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Fig. 1. Age distribution of walking (top) and cycling (bottom) across E&W and three com-
parison areasa. aThe data is population based including people who did not travel.
Communities b 10,000 and subjects b 16 years are excluded. E&W: N (persons) =
74,958, Source: Department of Transport, 2013. National Travel Survey statistics, 7/30/
2013 ed. Switzerland: N (persons)= 40,473, Source:Mobilität in der Schweiz: Ergebnisse
des Mikrozensus 2005 zum Verkehrsverhalten. Bundesamt fuer Statistik, Neuchatel.
Netherlands N (persons) = 28,188, Source: Ministerie van Verkeer en Waterstaat, 2010.
“Onderzoek Verplaatsingen in Nederland” (OViN). California N (persons) = 37,380,
Source: Federal Highway Administration, 2010. National Household Travel Survey. US
Department of Transportation.
45T. Götschi et al. / Preventive Medicine 74 (2015) 42–48
relationship is non-linear, less active individuals beneﬁt more from
increasing physical activity than those already active. The calculation
also assumes no effect on other physical activities from shifting travel
patterns. As shown, the dose–response function is quite inﬂuential,
but there is no scientiﬁc consensus on its exact shape or how it may
vary by disease (Samitz et al., 2011; Sattelmair et al., 2011; Woodcock
et al., 2011). A power transformation of 0.25 attributes a large part of
beneﬁts to moving from no activity to low levels of activity, whereas a
closer to linear shape distributes beneﬁts more evenly across a wider
exposure range.
The presented analysis is limited by its focus on beneﬁts from
physical activity. Increases in active travel could also lead to increased
risk for crashes and increased exposure to air pollution. Previous studies
indicate that if a population wide change in behaviour is achieved then
beneﬁts from physical activity by far outweigh these risks either at
population or individual level (de Hartog et al., 2010; Woodcock et al.,
2009).
This study points to several research needs. Handling non-linear
dose–response functions and non-normal distributions of key
parameters remain challenges. Meta-analyses of active travel related
relative risks and dose–response functions are needed. Travel
surveys combined with objective measurements should collect
improved data including intensity of walking and cycling, ideally
complemented by items on overall physical activity. Ultimately,
policy evaluations should collect adequate data to link ﬁndings
from health impact modelling directly to prior investments made
to achieve shifts towards healthier travel patterns.
Conclusions
International surveys can be used to inform scenario calculations for
increasingly sophisticated health impact models of active travel. Travel
survey data would be even more valuable, if items on physical activity
were included and international calibration would increase feasibility
of such comparisons.
If E&Wadoptedwalking and cycling patterns of Switzerland and the
Netherlands this could be expected to confer major health beneﬁts. As
such, the presented ﬁndings provide strong support for investments in
efforts to increase levels of active travel.
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Table 5a
Changes in DALYs (left) and deaths (right) in England &Wales (age 15+) if adopting travel patterns from comparison areas (based on absolute travel times) (Median (95% credible in-
terval)). (See Table 5b for adopting relative travel time distribution across modes).
Baseline
DALYs in
England &
Wales
Adopted travel pattern from Baseline
deaths in
England &
Wales
Adopted travel pattern from
Switzerland Netherlands California Switzerland Netherlands California
Males
Stroke 201,995 −21,310 (−33,140 to
−11,870)
−18,090 (−29,380 to
−9480)
3365 (2026 to
4851)
14,047 −1525 (−2344 to
−862)
−1121 (−1795 to
−600)
226 (134 to
335)
Ischemic heart disease 620,598 −63,400 (−99,070 to
−35,100)
−57,950 (−94,640 to
−30,150)
10,220 (6150 to
14,710)
38,329 −4,122 (−6376 to
−2312)
−3293 (−5314 to
−1743)
629 (377 to
917)
Other cardiovascular and
circulatory diseases
171,381 −17,770 (−27,730 to
−9856)
−15,800 (−25,780 to
−8224)
2877 (1735 to
4134)
10,388 −1127 (−1741 to
−633)
−875 (−1408 to
−465)
171 (102 to
250)
Type-2 diabetes 64,498 −6546 (−10,630 to
−3177)
−6145 (−10,380 to
−2838)
1091 (546 to
1707)
1850 −207 (−333 to
−102)
−164 (−272 to
−77)
32 (16 to
50)
Colon cancer 76,689 −3884 (−7299 to
−738)
−3774 (−7126 to
−722)
530 (92 to
1073)
4375 −238 (−446 to
−46)
−208 (−389 to
−40)
32 (5 to 65)
Breast cancer – – – – – – – –
Dementia and Alzheimer's
disease
89,714 −7163 (−11,150 to
−3428)
−5571 (−8655 to
−2671)
918 (380 to
1682)
5366 −431 (−672 to
−206)
−303 (−471 to
−146)
51 (20 to
98)
Depression 137,704 −7715 (−20,770 to
−1319)
−8929 (−24,180 to
−1416)
1168 (225 to
3109)
– – – –
Total 1,362,578 −127,800 (−196,500
to−75,850)
−116,300 (−188,800
to−63,700)
20,160 (13,500
to 27,460)
74,357 −7651 (−11,420
to−4611)
−5963 (−9290 to
−3400)
1140 (718 to
1637)
Females
Stroke 226,967 −24,630 (−37,100 to
−14,230)
−15,950 (−23,920 to
−9249)
2421 (1438 to
3568)
22,603 −2506 (−3711 to
−1472)
−1191 (−1699 to
−717)
154 (76 to
263)
Ischemic heart disease 337,852 −36,580 (−55,360 to
−21,050)
−25,730 (−38,990 to
−14,790)
3933 (2368 to
5685)
31,224 −3456 (−5135 to
−2023)
−1786 (−2574 to
−1066)
239 (128 to
389)
Other cardiovascular and
circulatory diseases
149,553 −16,040 (−24,320 to
−9215)
−11,440 (−17,420 to
−6537)
1811 (1093 to
2606)
12,442 −1375 (−2043 to
−805)
−710 (−1024 to
−424)
96 (52 to
156)
Type-2 diabetes 56,938 −6199 (−9903 to
−3067)
−5075 (−8239 to
−2471)
829 (423 to
1260)
1977 −226 (−354 to
−115)
−125 (−191 to
−64)
17 (8 to 29)
Colon cancer 58,147 −2140 (−4100 to
−294)
−1804 (−3470 to
−248)
238 (31 to 484) 3,850 −151 (−287 to
−21)
−99 (−189 to
−14)
12 (1 to 26)
Breast cancer 201,757 −8966 (−17,870 to
−3637)
−8514 (−17,530 to
−3262)
1078 (527 to
1877)
9096 −429 (−819 to
−185)
−336 (−658 to
−139)
40 (21 to
65)
Dementia and Alzheimer's
disease
151,156 −12,450 (−19,590 to
−5902)
−6693 (−10,770 to
−3114)
718 (247 to
1577)
11,873 −1000 (−1586
to−471)
−433 (−729 to
−192)
34 (6 to 95)
Depression 230,906 −16,030 (−42,830 to
−2829)
−17,010 (−45,680 to
−2871)
2899 (563 to
7611)
– – – –
Total 1,413,276 −123,000 (−188,600
to−76,930)
−92,230 (−148,900
to−55,040)
13,930 (9748 to
18,840)
93,067 −9144 (−12,910
to−5947)
−4678 (−6417 to
−3121)
592 (343 to
948)
Total (males + females) 2,775,854 −250,800
(−384,100 to
−153,300)
−208,500
(−336,900 to
−119,200)
34,090 (23,630
to 45,210)
167,423 −16,800 (−24,320
to−10,580)
−10,640
(−15,660 to
−6595)
1732 (1072
to 2575)
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